Join
Live feed
·
INSIDERFilingvia Quantisnow
Edesa Biotech Inc. logo

Chief Financial Officer Weiler Peter J. was granted 65,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
EDSA· Edesa Biotech Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EDSA (Edesa Biotech Inc.) and more on Quantisnow.